The association between prior infection with five serotypes of Coxsackievirus B and incident type 2 diabetes mellitus in the EPIC-Norfolk study

Diabetologia

Volumn 55, Issue 4, 2012, Pages 967-970

  Gkrania Klotsas, E ^a   Langenberg, C ^a   Tauriainen, S ^b   Sharp, S J ^a   Luben, R ^c   Forouhi, N G ^a   Khaw, K T ^c   Hyoty H ^b,d   Wareham, N J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cohort study; CoxsackievirusB; EPIC Norfolk; Type 1 diabetesmellitus; Type 2 diabetesmellitus

Indexed keywords

NEUTRALIZING ANTIBODY;

ADULT; AGE; AGED; ARTICLE; ASSAY; BODY MASS; COHORT ANALYSIS; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; DIABETOGENESIS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FOLLOW UP; GENDER; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEROTYPE;

ADULT; COXSACKIEVIRUS INFECTIONS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENTEROVIRUS B, HUMAN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; RISK FACTORS;

EID: 84862534052     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2443-7     Document Type: Article

References (9)

1. Hardoon SL, Morris RW, Thomas MC, Wannamethee SG, Lennon LT, Whincup PH (2010) Is the recent rise in type 2 diabetes incidence from 1984 to 2007 explained by the trend in increasing BMI?: Evidence from a prospective study of British men. Diabetes Care 33:1494-1496
2. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19
3. Roivainen M, Rasilainen S, Ylipaasto P et al (2000) Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 85:432-440
4. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52:1143-1151
5. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) Islet-associated macrophages in type 2 diabetes. Diabetologia 52:1686-1688
6. Klemola P, Kaijalainen S, Ylipaasto P, Roivainen M (2008) Diabeto-genic effects of the most prevalent enteroviruses in Finnish sewage. Ann N Y Acad Sci 1150:210-212
7. Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T (2002) Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 45:693-702
8. Bell EJ, McCartney RA (1984) A study of Coxsackie B virus infections, 1972-1983. J Hyg 93:197-203
9. Singh IP, Chopra AK, Coppenhaver DH, Ananatharamaiah GM, Baron S (1999) Lipoproteins account for part of the broad nonspecific antiviral activity of human serum. Antivir Res 42:211-218